Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study.
about
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika VirusProspects for dengue vaccines for travelersBenefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deploymentVaccines and immunization strategies for dengue preventionThe Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.Immune correlates of protection for dengue: State of the art and research agenda.Zika Virus: Immunity and Vaccine Development.Current management of severe dengue infection.Vaccines licensed and in clinical trials for the prevention of dengue.Development of Peptide Vaccines in Dengue.First evidence of dengue infection in domestic dogs living in different ecological settings in Thailand.
P2860
Q26247258-A6CF2DAD-94E4-435A-853F-23FD725715A3Q26314423-FCB8237A-13B6-41C1-8F3C-306DAA95A8A8Q26746185-6D13D144-C5F1-4E28-B64A-85F8A5C25EB6Q28077521-CD0869E0-6330-4931-9527-57B9C17789B6Q36206719-1D927F94-6FFD-47C1-A353-D0A190E57F87Q38652971-B661FFB8-1E5B-4B24-8AB9-FBACA8AFE5D1Q38969772-3A4A2567-FF5A-4A71-BD7F-E052A7D03F78Q38992396-AEBB694D-597B-4F0C-91C4-055AD37E1E1FQ39172722-776CC47A-CF03-4CB1-8A05-BE88BEDE61CFQ40038715-1199D640-17E3-45F7-BDDB-5007C4304393Q40064987-204BF7F4-0CFD-4B09-A837-CFD8FF8A9FE6
P2860
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety and Immunogenicity of a ...... cebo-Controlled Phase 2 Study.
@en
Safety and Immunogenicity of a ...... cebo-Controlled Phase 2 Study.
@nl
type
label
Safety and Immunogenicity of a ...... cebo-Controlled Phase 2 Study.
@en
Safety and Immunogenicity of a ...... cebo-Controlled Phase 2 Study.
@nl
prefLabel
Safety and Immunogenicity of a ...... cebo-Controlled Phase 2 Study.
@en
Safety and Immunogenicity of a ...... cebo-Controlled Phase 2 Study.
@nl
P2093
P2860
P356
P1476
Safety and Immunogenicity of a ...... cebo-Controlled Phase 2 Study.
@en
P2093
Carlos A Sariol
Chukiat Sirivichayakul
Dan T Stinchcomb
Derek Wallace
Elizabeth A Barranco-Santana
Gilad S Gordon
Helen M L Oh
Inés Esquilin-Rivera
Ivan Dario Velez
Marsha Raanan
P2860
P304
P356
10.1093/INFDIS/JIV762
P407
P577
2015-12-23T00:00:00Z